Patent · US Active

Compositions and methods of treating facioscapulohumeral muscular dystrophy

US11912779B2 · kind B2 · utility

4Cited by
111References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 15, 2022
Grant dateFeb 27, 2024
Priority date—
Expiry dateSep 15, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/3515
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.